Ipsen Biopharma
INCRELEX
Manufacturer:
Ipsen Biopharma
Name:
INCRELEX
HCPCS Code Descriptor:
Injection, mecasermin, 1 mg
Category:
J Code
HCPCS:
J2170
NDC(s):
15054-1040-05
Primary Type:
Growth Disorder
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
INCRELEX is a Growth Disorder drug manufactured by Ipsen Biopharma and administered via the Subcutaneous route of administration. The J Code: J2170 is aligned to the drug INCRELEX.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/07
HCPCS Effective Date:
1/1/07
HCPCS Short Description:
Mecasermin injection
Billing and Coding Guide:
https://www.ipsencares.com/sites/g/files/kcxpwu526/files/2022-08/INC-US-001135-Increlex-Coding-Flashcard-November-2020_approved_1.21.21.pdf
Patient Assistance:
http://www.ipsencares.com/